You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 8, August 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Facial Plastic Surgery
 •Cosmetic Surgery/ Procedures
 •Pain
 •Dermatologic Disorders, Other
 •Drug Therapy
 •Alert me on articles by topic

Successful Treatment of Notalgia Paresthetica With Botulinum Toxin Type A

Pamela Kirschner Weinfeld, MD

Arch Dermatol. 2007;143(8):980-982.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Notalgia paresthetica is a chronic condition that, while not life threatening, produces symptoms that are incessant and onerous to many patients. To date, there has been no effective, long-lasting, noninvasive treatment for this condition, which decreases the patient's quality of life.


REPORT OF CASES

CASE 1

A 52-year-old white woman presented with a 2- to 4-year history of pruritus of her upper back, which she described as a 7 on a severity scale of 1 to 10. She reported scratching her back twice a day. She had tried moisturizers and topical corticosteroids with no improvement. She recalled that her father had had a similar itch on his back for years that induced him to repeatedly scratch his back on a doorpost. Her medical history was remarkable only for gastroesophageal reflux disease, which was responsive to ranitidine, and for rosacea, for which she used topical metronidazole. She had no drug allergies. On . . . [Full Text of this Article]

CASE 2

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT

AUTHOR INFORMATION

Division of Dermatology, Newton-Wellesley Hospital, Newton, Massachusetts


RELATED ARTICLE

The Cutting Edge
George J. Hruza
Arch Dermatol. 2007;143(8):1062.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Cutting Edge
Hruza
Arch Dermatol 2007;143:1062-1062.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.